文献速递神经肿瘤

多发性原发性颅内神经内分泌癌的病理进展、可能起源与管理

Pathologic Progression, Possible Origin, and Management of Multiple Primary Intracranial Neuroendocrine Carcinomas.
PubMed 文献 · World Neurosurg · 2017-07-21

本文报告一例56岁女性多发性原发性颅内神经内分泌癌(NEC),影像学模仿多发性颅内脑膜瘤,先后接受3次手术(左顶骨开颅、右枕顶骨开颅、左额开颅),前两次病理诊断为脑膜瘤后修正为NEC,第三次为典型NEC;术后行全脑放疗和替莫唑胺联合YH-16全身化疗,10个月随访结局良好。作者认为肿瘤可能源于蛛网膜或软脑膜,有症状占位需最大程度手术切除,术后放化疗应为推荐治疗方式。

要点

  • 多发性原发性颅内NEC极罕见,可模仿多发性脑膜瘤,病理可误诊为脑膜瘤。
  • 肿瘤可能源于蛛网膜或软脑膜,组织学模式可能发生转化和/或进展。
  • 有症状占位需最大程度手术切除,术后放化疗应为推荐治疗方式。

核心结论

  • 多发性原发性颅内NEC极罕见,肿瘤可能源于蛛网膜或软脑膜,组织学模式可能发生转化和/或进展。
  • 有症状占位需最大程度手术切除,术后辅助治疗包括放疗和化疗应为推荐治疗方式。

研究设计与样本

  • 个案报告:一例56岁女性多发性颅内NEC,表现为模仿多发性颅内脑膜瘤。
  • 患者先后接受3次手术:左顶骨开颅、右枕顶骨开颅、左额开颅。

主要发现

  • 第一和第二肿瘤确诊为NEC,但组织学表现出典型间变性脑膜瘤特征,有旋涡形成。
  • 第三肿瘤为典型NEC,具有器官样癌巢特征。
  • 前2个病灶最初诊断为脑膜瘤而非NEC,第三次手术后复核并修正诊断。
  • 第三次手术切除后,患者接受全脑放疗和全身化疗(替莫唑胺联合YH-16)。
  • 10个月随访时患者结局良好。

临床怎么用

  • 作者认为,有症状占位需最大程度手术切除。
  • 作者认为,术后辅助治疗包括放疗和化疗应为推荐治疗方式。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary intracranial neuroendocrine carcinomas (NECs) are extremely rare malignant tumors with no previous reports of multiple ones in the literatures. CASE DESCRIPTION: The clinical presentation, preoperative and reexamined magnetic resonance imaging findings, as well as histopathologic studies of a 56-year-old female subject with multiple intracranial NECs mimicking multiple intracranial meningiomas, who underwent 3 operations with left parietal craniotomy, right occipital parietal craniotomy, and left frontal craniotomy, separately and chronologically, are presented in this article. Noteworthy, the first and second tumors were confirmed as NECs exhibiting histologic characteristics of typical anaplastic meningiomas with features of whorl formation, while the third tumor was a typical NEC with features of organoid cancer nests. In other words, the first 2 lesions were diagnosed as meningioma as opposed to NEC. It was only after the third surgery that the pathology for the first 2 cases was reviewed and had a revised diagnosis. After the third surgical resection, the patient further received whole brain radiotherapy and systemic chemotherapy (temozolomide combined with YH-16). At her 10-month follow-up, the patient achieved a good outcome. CONCLUSIONS: Multiple primary intracranial NECs are extremely rare. The tumor might be of arachnoidal or leptomeningeal origin, with histologic patterns that might lead to transformation and/or progression. Maximal surgical resection is warranted for symptomatic mass effect. Postoperative adjuvant treatments including radiotherapy and chemotherapy should be a recommended therapeutic modality.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cao J, Xu W, Du Z, et al. Pathologic Progression, Possible Origin, and Management of Multiple Primary Intracranial Neuroendocrine Carcinomas. World Neurosurg. 2017. PMID: 28736348. doi:10.1016/j.wneu.2017.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。